MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20254465

June 3, 2025

Drug Information

注射用氯诺昔康

注射剂

8mg(每瓶实装8.6mg)

化学药品

June 3, 2025

Company Information

Applicant Company

重庆市南岸区长生桥镇玉马路8号A栋401-01-03(自主承诺)

Manufacturing Company

重庆市南岸区玉马路99号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath